Galapagos backpedals on separation plans, CEO Paul Stoffels exits earlynews2025-05-13T11:23:05+00:00May 13th, 2025|Endpoints News|
Exclusive: Patrick Hsu’s startup Stylus Medicine launches, looks beyond CRISPR for gene insertion technews2025-05-12T15:27:02+00:00May 12th, 2025|Endpoints News|
CRISPR isn’t living up to its potential. Two scientists have a plan to fix thatnews2025-05-08T14:00:20+00:00May 8th, 2025|Endpoints News|
CRISPR Therapeutics’ gene editing therapy reduces bad cholesterol and triglycerides by as much as 80%news2025-05-07T11:00:16+00:00May 7th, 2025|Endpoints News|
Singapore cardio gene therapy biotech collects $45M as it plots Europe expansionnews2025-05-06T05:00:34+00:00May 6th, 2025|Endpoints News|
FDA adcomm to review Capricor’s Duchenne cell therapynews2025-05-05T20:07:53+00:00May 5th, 2025|Endpoints News|
J&J eye disease gene therapy bota-vec fails Phase 3news2025-05-05T13:29:50+00:00May 5th, 2025|Endpoints News|
Early in vivo CAR-T human data emerge from biotech trials in Chinanews2025-05-05T10:00:52+00:00May 5th, 2025|Endpoints News|
Vertex drops AAV gene therapy research, tRNA therapy partnershipnews2025-05-02T19:29:13+00:00May 2nd, 2025|Endpoints News|
Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipelinenews2025-05-02T15:32:11+00:00May 2nd, 2025|Endpoints News|
